secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2026-05-22T20:19:44+00:00
Accession:  0001628280-26-037735
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics stockholders approve 5M share increase to 2023 equity plan, elect all director nominees
--------------------------------------------------------------------------------

- All nine director nominees elected; Lynn Tetrault received 105.7M votes for (96.9% of votes cast).
- Advisory say-on-pay passed with 83.19% of votes cast in favor.
- Amendment to 2023 equity plan increasing authorized shares by 5,000,000 approved with 97.9% of votes cast.
- Ratification of Deloitte as independent auditor approved with 99.57% of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000162828026037735/0001628280-26-037735-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000162828026037735/neo-20260521.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-037735

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer